banner
EGFR-HER2 inhibitor DBPR112, Purity ≥98%

Cat. No.: X24-05-ZQ678

EGFR-HER2 inhibitor DBPR112, Purity ≥98%

Synonym: 1226549-49-0; DBPR 112; DBPR-112; EGFR-HER2 inhibitor

  • CAS Number: 1226549-49-0
  • Compound CID: 46212971
Product Size
5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
DBPR112 is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR (L858R)/T790M and EGFRWT.
Molecular Weight
533.62
Molecular Formula
C32H31N5O3
Targets
EGFR (L858R)/T790M: 48 nM; EGFRWT: 15 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
DBPR112 can be used to investigate its role as an EGFR tyrosine kinase inhibitor in cancer studies.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

  • SUITE 201, 17 Ramsey Road, Shirley, NY 11967, USA
  • 1-631-637-6119
Copyright © 2025 CD BioGlyco. All rights reserved.
0

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x